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Abstract
Bovine rhinitis viruses (BRV) are established etiological agents of bovine respiratory dis-
ease complex however little research into their epidemiology and ecology has been pub-
lished for several decades. In the U.S., only bovine rhinitis A virus 1 (BRAV1) has been
identified while bovine rhinitis A virus 2 (BRAV2) and bovine rhinitis B virus (BRBV) were
previously only identified in England and Japan, respectively. Metagenomic sequencing of
a nasal swab from a bovine respiratory disease (BRD) diagnostic submission from Kansas
identified contigs with approximately 90% nucleotide similarity to BRAV2 and BRBV. A com-
bination of de novo and templated assemblies using reference genomes yielded near com-
plete BRAV2 and BRBV genomes. The near complete genome of bovine rhinitis A virus 1
(BRAV1) was also determined from a historical isolate to enable further molecular epidemi-
ological studies. A 5’-nuclease reverse transcription PCR assay targeting the 3D polymer-
ase gene was designed and used to screen 204 archived BRD clinical specimens. Thirteen
(6.4%) were positive. Metagenomic sequencing of six positive samples identified mixed
BRAV1/BRAV2, BRAV1/BRBV and BRAV2/BRBV infections for five samples. One sample
showed infection only with BRAV1. Seroprevalence studies using a cell culture adapted
BRBV found immunofluorescence assay-reactive antibodies were common in the herds an-
alyzed. Altogether, these results demonstrate that BRV infections are common in cattle with
respiratory disease and that BRAV1, BRAV2 and BRBV co-circulate in U.S. cattle and have
high similarity to viruses isolated more than 30 years ago from diverse locations.
Introduction
Along with equine rhinitis virus (ERV) and foot and mouth disease virus (FMDV), bovine rhi-
nitis A and B viruses (BRAV and BRBV, respectively) are species in the genus Aphthovirus,
family Picornaviridae [1]. Two serotypes of BRAV have been identified, BRAV1 and BRAV2,
while BRBV consists of a single serotype. The BRAV1 strain SD-1 was isolated in Germany in
1962 from nasal secretions from a calf with rhinitis [2]. Additional BRAV1 strains were subse-
quently isolated from both healthy and diseased bovines in England, Japan, Italy and the U.S.
and shown to cross react in serum neutralization assays [3–6]. The sole BRBV isolate EC-11
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was isolated in England in 1964 by Reed from the lung of a specific pathogen free calf with re-
spiratory disease [7]. Likewise, BRAV2 consists of a single specimen, strain H-1, isolated from
an outbreak of respiratory disease in cattle in 1984 [8]. Despite numerous studies on bovine
rhinitis viruses (BRV) in the 1960’s through mid-1980’s, little work has been published on their
epidemiology and ecology the past several decades.
Bovine respiratory disease complex (BRDC) is the most economically significant disease of
the cattle industry, leading to losses due to mortality, morbidity, treatment costs and feed inef-
ficiency in excess of $750 million dollars per year in the U.S. alone [9]. BRDC has a multifacto-
rial etiology involving a variety of bacteria and viruses in addition to host and environmental
factors [10]. Numerous commercial vaccines including both killed and attenuated live bacteria
are available. Viruses commonly included in commercial vaccine include bovine viral diarrhea
virus (BVDV), bovine herpes virus 1 (BHV1), parainfluenza virus 3 (PI3) and bovine respirato-
ry syncytial virus (BRSV). Despite their widespread use, BRDC incidence has increased over
the past 20 years [11,12]. BRDC pathogenesis often involves a primary viral infection which
damages respiratory mucosa and alters host immune responses leading to secondary bacterial
pneumonia caused by commensal bacteria already present in the respiratory tract [13].
Both BRAV and BRBV are established but rarely studied etiologic agents of BRDC. Experi-
mental inoculation of calves with BRAV1 via intranasal (IN) or intratracheal (IT) routes, either
singly or in combination, resulted in variable clinical signs of respiratory disease and histologic
lesions consistent with pneumonia [14]. BRAV1 was also recovered from nasal swabs of IN in-
oculated animals and all animals inoculated or exposed by contact seroconverted to BRAV1 by
day seven post inoculation. A similar experiment using a different BRAV1 strain (RS 3x) and
colostrum deprived calves failed to reproduce clinical disease but was successful in isolating
BRAV1 from nasal swabs post inoculation and found histological lesions of focal rhinitis and a
neutralizing antibody response in all inoculated calves [15]. BRBV pathogenesis was investigat-
ed using intranasal inoculation of gnotobiotic calves [16]. Clinical signs including fever, nasal
discharge and increased respiration rate were observed. Foci of epithelial necrosis were ob-
served histologically in the turbinates and trachea and interstitial pneumonia was evident in
the lungs. Virus was isolated from multiple tissues and was neutralized by convalescent antise-
rum. In addition to controlled studies, numerous investigations of acute respiratory disease in
cattle resulted in the isolation of bovine rhinitis viruses where paired acute and convalescent
sera suggested a causative role for bovine rhinitis virus [6,8,17,18].
Metagenomic sequencing on nasal swabs obtained from BRDC diagnostic submissions were
performed to survey viruses present. Contigs with high identity to BRAV2 and BRBV were
identified in one swab. To further our understanding of the epidemiology and ecology of bo-
vine rhinitis viruses in BRDC, a more comprehensive survey was performed.
Materials and Methods
Ethics Statement
Bovine clinical samples used in this study were submitted to KSVDL for routine diagnostic
testing. The samples were obtained from naturally infected animals in the field by licensed vet-
erinarians as a part of normal veterinary care and diagnostic investigations.
Molecular screening of bovine viruses
Clinical samples (nasal and pharyngeal swabs and lung tissue) from bovine respiratory disease
submissions to KSVDL were screened by a BRDC PCR panel which detects BVDV, BHV-1,
BRSV and bovine coronavirus (BCV) [19]. A total of 204 samples were screened. Samples were
collected in years 2011–2014 from twelve states: Nebraska (n = 48), Kansas (n = 112), Colorado
Bovine Rhinitis Viruses in Cattle with Respiratory Disease
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(n = 6), Missouri (n = 1), Mississippi (n = 7), Texas (n = 4), Oklahoma (n = 2), Idaho (n = 2),
Montana (n = 6), Oregon (n = 4), Washington (n = 11) and Virginia (n = 1). Samples were also
screened for influenza D virus (IDV) using quantitative real time reverse transcription PCR as
previously described [20]. A 5’-nuclease reverse transcription PCR assay was designed to detect
bovine rhinitis viruses targeting the 3D polymerase gene: probe, 5’-FAM-CGG CAG TCC
AGG TCC AGT GT-Iowa Black-3’; Forward: 5’-CTT TTC GGT GTG ATT GGC AG-3’; Re-
verse: 5’-GAA ATC TAT CAG GGC AGG TCT G-3’. Viral RNA was extracted using the Mag-
MAX-96 viral RNA isolation kit (Life Technologies) according to the manufacturer’s
instructions. Real time reverse transcription PCR was performed using Qiagen Quantitect
RT-PCR with BRV primers and probe as follows: 50°C, 30 minutes; 95°C, 15 minutes; followed
by 40 cycles of 94°C for 15 seconds and 60°C for 60 seconds. The PCR assay specificity was
confirmed using bovine rhinitis virus positive samples as determined by metagenomic se-
quencing as well as with cultures of common BRDC pathogens BVDV, BHV-1, BRSV, BCV,
Mannheimia haemolytica,Histophilus somni, Pasteurella multocida andMycoplasma bovis.
Metagenomic Sequencing
Sample preparation for metagenomic sequencing was performed similar to previously de-
scribed [21]. In brief, swabs or tissue homogenate were clarified by centrifugation followed by
filtration through a 0.2 micron syringe filter. Samples (180 μl) were treated with a cocktail of
nucleases to degrade host or unprotected environmental nucleic acids at 37°C for 90 minutes.
Viral nucleic acids were isolated using the MinElute Virus spin filter kit (Qiagen) according to
the manufacturer’s instructions. Reverse transcription was performed using primers consisting
of a known 20 nt sequence followed by (N)6 at the 3’ end [22] using a Superscript III reverse
transcription kit (Life Technologies). Second strand synthesis was performed using Sequenase
2.0 (Affymetrix). Double stranded cDNA was purified using a Qiagen Minelute PCR spin col-
umn and subsequently amplified using primers identical to the known 20bp region of the ran-
dom hexamer containing primer. Amplicons were purified using a Qiagen Minelute PCR spin
column and quantified using a Qubit fluorimeter (Life Technologies). Samples were diluted to
0.2 ng/μl and 5μL was used for sequencing library preparation using the Nextera XT library
preparation kit (Illumina) according to manufacturer’s instructions. Pooled barcoded libraries
were sequenced on an Illumina MiSeq instrument using paired 150bp reads.
Reads from each sequencing library were parsed into individual folders based on barcoded
sequences. Reads were imported into the CLC Genomics software package (Qiagen). Reads
were mapped to the host genome (Bos taurus) and unmapped reads were collected. De novo as-
sembly was performed on unmapped reads and assembled contigs were analyzed by BLASTN.
BRV genomes were assembled using a combination of de novo and templated assembly with
reference BRAV2 and BRBV genomes (GenBank JN936206 and EU236594, respectively). Raw
sequencing reads were submitted to the National Center for Biotechnology Information Se-
quence Read Archive under BioProject PRJNA273738 (accession number SRP052864). Acces-
sion numbers for the individual samples are SRR1776513 (sample 140032–4), SRR1776531
(sample 5–52), SRR1776533 (sample 6–17), SRR1776541 (sample 20–76), SRR1776564 (sam-
ple 21–22), SRR1776524 (sample 4–26) and SRR1776537 (sample 6–19). The genomes for
BRAV1 Sd-1, BRAV2 140032–1 and BRBV 140032–2 were submitted to GenBank under acces-
sions KP236128, KP236129 and KP236130, respectively. Phylogenetic analyses were performed
by using Mega6.06 software using the Maximum Likelihood algorithm with tree topology veri-
fied by performing 1000 bootstrap replicates [23].
Bovine Rhinitis Viruses in Cattle with Respiratory Disease
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Cells and Viruses
Fetal bovine kidneys, sourced from an abattoir, were purchased from Innovative Research. Pri-
mary embryonic bovine kidney (EBK) cells were cultured by treatment of finely minced kid-
neys with 0.25% trypsin at 37°C for 4 hours following transfer to cell culture flasks with MEM
with L-glutamine and 100 units/mL penicillin, 100 μg/mL streptomycin and 0.25 μg/mL am-
photericin B. Madin-Darby bovine kidney (MDBK) (ATCC CCL-22) were maintained in
MEM with L-glutamine and 5% fetal calf serum at 37°C with 5% CO2. BRBV (ATCCVR-1806)
was first passaged on EBKs before being expanded on MDBK cells. Virus was grown in MEM
at 33°C with 5% CO2.
Indirect immunofluorescence assay
Indirect immunofluorescence was performed using 59 bovine serum samples submitted for di-
agnostic testing at KSVDL. The samples were originated from Kansas (n = 36), Illinois (n = 5),
Missouri (n = 9), Texas (n = 2), Colorado (n = 2) and Idaho (n = 5) from beef and dairy herds.
Antiserum from a gnotobiotic calf hyperimmunized with BCV was used as a negative control
(National Veterinary Services Laboratories catalog #320-BDV). Sera from two high health
cows housed in isolation at the Kansas State University Veterinary Health Center were also
used as negative controls. Non-infected cells were also stained to determine level of background
fluorescence. MDBK cells were infected with BRBV at a dilution of 1:15 and incubated over-
night. Once the onset of cytopathic effect (CPE) was evident in approximately 20% of the cells,
plates were washed with PBS and fixed in 80% aqueous acetone. Serum was added at a 1:10 di-
lution and seven serial two-fold dilutions were made in PBS, with a final serum dilution of 640.
Plates were incubated for 1 hour at 37°C, then washed three times with PBS. FITC-conjugated
rabbit anti-bovine IgG (Jackson Immunoresearch) was added at a dilution to 1:50, along with
Evan’s Blue at 1:500, and incubated for 1 hour at 37°C. Plates were then washed three times
with PBS and 100 μL of 50% glycerol in PBS was added to each well and subsequently read on a
fluorescence microscope.
Results and Discussion
Metagenomic Sequencing of Clinical Sample
In September, 2013, nasal swabs were submitted to the Kansas State Veterinary Diagnostic
Laboratory (KSVDL) from an approximately 6-month old calf in Kansas with acute respiratory
disease. Aerobic culture identifiedMannheimia haemolytica. A bovine respiratory disease PCR
panel was also performed and was positive forMycoplasma bovis [cycle threshold (Ct) = 27.8]
and bovine coronavirus (BCV, Ct = 20.0). Metagenomic sequencing was next performed on
the sample to investigate BCV genetic diversity for an unrelated project. The nasal swab sample
was filtered through a 0.2 micron syringe filter and treated with a cocktail of nucleases before
nucleic acid isolation. Reverse transcription, second strand synthesis and amplification were
performed using sequence independent single primer amplification (SISPA) and sequencing li-
braries were prepared from the resulting amplicons [22]. Approximately 4 million reads were
generated on an Illumina MiSeq instrument. Reads mapping to host DNA were subtracted
(*3.6M reads) and the remaining sequences (*430k reads) were assembled de novo into 192
contigs and classified based on best BLASTN expectation (E) scores. Besides the expected BCV,
contigs with similarity to bovine adenovirus 4 (BAdV4), BRAV2 and BRBV were identified
with E values of 0. Templated assembly was next performed using reference genomes identified
by BLAST analysis. A near complete BCV genome was assembled from 15,500 reads to yield a
consensus sequence of 31,017 nucleotides (nt) (missing the 5’-terminal 4 nt) with 99% identity
Bovine Rhinitis Viruses in Cattle with Respiratory Disease
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to strain E-AH65 [24]. Significantly fewer reads mapped to BAdV4 (238 reads) which resulted
in*25% genome coverage with 91% identity to strain THT/62 [25]. Assembly using a BRAV2
reference genome mapped 5,924 reads which spanned the 5’-non coding region and the com-
plete polyprotein open reading frame with the exception of a 16 nt gap approximately 150 nt
from the 3’-end of the polyprotein. The determined BRAV2 sequence was 89% identical to the
BRAV2 strain H-1. Similarly, assembly using the BRBV reference genome identified 2,505
reads which spanned the entire reference sequence with the exception of 48 and 13 nt at the 5’
and 3’-termini. The consensus sequence was 87% identical to BRBV strain EC11 [1]. As only a
single genome each of BRAV2 and BRBV have been published and neither of the viruses have
previously been identified in U.S. cattle, further investigation was warranted.
Genome Sequence BRAV1 strain Sd-1
There are two serotypes of BRAV, 1 and 2. While the genome sequence of BRAV2 strain H-1 is
available in GenBank, no sequence for BRAV1 is available. To enable further molecular epide-
miology studies on bovine rhinitis viruses, the genome of BRAV1 strain Sd-1 was determined.
BRAV1 Sd-1 was obtained from American Type Culture Collection (ATCC) and sequenced
using metagenomic sequencing methodology as described above directly from cell culture har-
vests of BRAV1 Sd-1 obtained from ATCC. Genome assembly was performed using a combi-
nation of de novo and templated assemblies using the BRAV2 strain H-1 reference. A 7,245 bp
contig with 82% identity to BRAV2 H-1 was determined from*200,000 reads mapping to
BRAV2 spanning the entire BRAV2 H-1 reference sequence with the exception of the 5’-termi-
nal 4 nt.
BRAV1 strain Sd-1 Sequence Analysis
Similar to all picornaviruses, the genome of BRAV1 consists of a long 5’ non-translated region
(NTR), a single large ORF encoding a polyprotein and a short 3’-NTR followed by a poly-A
tail. The region of the 5’ NTR sequenced encompasses 537 nt and is 89% identical to BRAV2
H-1. The 5’ NTR contained three insertions (G334, C350, C527) and one deletion (A345) as
compared to BRAV2 H1. The Aphthovirus 5’NTR contains a type II internal ribosome entry
site [26–28]. The polyprotein initiation codon is typically preceded by a polypyrimidine tract
by approximately 20 nt’s. A polypyrimidine tract is present in BRAV1 from nt 514–522
(UUUUCCUUU) followed by an AUG initiation codon at nt 538–540. A second initiation
codon is present closely downstream and in the same reading frame at nt 553–555. Aphtho-
viruses typically express two different forms of the leader polypeptide (Lab and Lb) from alter-
nate initiation codons [29–30]. FMDV favors translation from the second initiation codon
while ERAV favors the first AUG. AUG codons favored for translation are located in the con-
text of Kozak sequences [31]. For BRAV1, the second AUG from nt 553–555 is in the context
of a strong Kozak sequence and expression of a 2,213 amino acid polyprotein is expected to be
dominant. The complete ORF of BRAV1 Sd1 encodes a predicted 2,218 amino acid polypep-
tide with 93% identity to BRAV2 and 50% identity to BRBV (Table 1). The polyprotein is pro-
cessed by viral proteases into L, four structural (VP4, VP2, VP3, VP1) and seven non-
structural (2A, 2B, 2C, 3A, 3B, 3C, 3D) proteins. The non-structural proteins of BRAV1 were
very similar to those of BRAV2 with over 90% identity. The most divergent proteins were the
capsid proteins VP1, VP2 and VP3 with 84.9–87.5% identity. VP1, VP2 and VP3 are the only
surface-exposed viral proteins and consequently are antigenic determinants [32,33]. As
BRAV1 and BRAV2 are serologically distinct, the sequence divergence observed between VP1,
VP2 and VP3 represents serotypic differences [8].
Bovine Rhinitis Viruses in Cattle with Respiratory Disease
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BRAV2 strain 140032–1 Sequence Analysis
The region of the 5’NTR of BRAV2 strain 140032–1 sequenced (487 nt) was 90% identical to
BRAV2 strain H-1 (Table 2). The 5’NTR contained four deletions (T195, T197, C343, A345)
and four insertions (T198, G199, C339, C341). A large ORF was identified from nt 488–7,219
encoding a predicted 2,243 amino acid polypeptide with 97% identity to BRAV2 H-1 that was
preceded by a polypyrimidine tract of CCCCUCUUU at nt 468–476. The L protein of BRAV2
strain 140032–1 was unusual such that it had four initiation codons in frame with the polypep-
tide within the first 100 bp of the ORF (nt’s 488–490, 539–541, 554–556 and 578–580). The lat-
ter initiation codon at 578–580 however was the only one associated with a Kozak sequence.
Further experimentation is required to determine which initiation codon(s) is used by BRAV2.
The L protein initiated at nt 488 is predicted to encode 204 amino acids and has only 82.4 and
82.8% identity to BRAV1 and BRAV2 strain H-1, respectively, and is the most divergent pro-
tein of 140032–1. The Lab proteins of BRAV1 and BRAV2 strain H-1 consist of 179 amino
Table 1. Amino acid length and sequence identity (%) between BRAV1 strain Sd-1 and other bovine rhinitis viruses.
Region Protein Length (aa) % Identity BRAV2 H-1 % Identity BRAV2 140032–1 % Identity BRBV EC-11 % Identity BRBV 140032–2
L 179 92.2 82.4 39.9 39.4
VP4 93 94.6 95.7 64.9 66.0
VP2 224 86.2 87.5 43.2 43.2
VP3 221 85.5 86.0 55.4 52.3
VP1 232 84.9 85.3 36.4 36.0
2A 20 90.0 95.0 35.9 35.9
2B 127 98.4 98.4 39.9 40.6
2C 311 97.4 98.1 59.6 59.6
3A 109 95.4 94.5 27.1 27.1
3B 24 95.8 100.0 50.0 50.0
3C 209 97.6 97.1 58.6 57.6
3D 469 97.9 98.1 58.9 58.6
Total 2218 93.2 92.7 50.4 50.1
doi:10.1371/journal.pone.0121998.t001
Table 2. Amino acid length and sequence identity (%) between BRAV2 strain 140032–1 and other bovine rhinitis viruses.
Region Protein Length (aa) % Identity BRAV1 Sd-1 % Identity BRAV2 H-1 % Identity BRBV EC-11 % identity BRBV 140032–2
L 204 82.4 82.8 41.4 40.9
VP4 93 95.7 97.9 64.9 66.0
VP2 224 87.5 98.2 43.7 43.2
VP3 221 86.0 97.7 51.8 50.5
VP1 232 85.3 97.4 36.4 37.7
2A 20 95.0 95.0 35.9 35.9
2B 127 98.4 100.0 39.1 39.9
2C 311 98.1 98.7 58.7 58.7
3A 109 94.5 97.3 27.1 27.1
3B 24 100.0 95.8 50.0 50.0
3C 209 97.1 99.5 58.1 57.1
3D 469 98.1 99.2 58.9 58.9
Total 2243 92.7 97.0 50.1 50.0
doi:10.1371/journal.pone.0121998.t002
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acids while the full length L protein of 140032–1 is more similar in length to that of BRBV (207
amino acids). The L protein autocatalytically cleaves the polyprotein at the L/P1 junction and
also catalyzes the cleavage of the p220 subunit of the cap binding complex eIF4G resulting in
inhibition of cellular cap-dependent translation initiation [34]. Further studies are required to
determine if translation initiation of 140032–1 occurs at all four codons and if these proteins
have similar biological properties. The structural and non-structural proteins of 140032–1 all
had>95% identity to BRAV2 H-1.
BRBV strain 140032–2 Sequence Analysis
A 566 nt region of the 5’NTR was sequenced for 140032–2 that was 93% identical to BRBV
strain EC-11 (Table 3). The 5’ NTR had a single insertion of a C at position 59 and a single de-
letion of C529. A large ORF from nt 567–7,409 was identified that codes for a predicted 2,280
amino acid polypeptide with 94.6% identity to EC-11. Similar to EC-11, two initiation codons
in frame with the polypeptide were identified near the 5’-terminus (nt’s 567–569 and 639–
641). Translation from the latter codon beginning at nt 639 is predicted to be more favorable as
it is in the context of a Kozak sequence. With the exception of proteins VP1 and 2A, all pro-
teins had greater than 92% identity to EC-11. Interestingly, VP1 showed only 86.8% amino
acid identity to EC-11. VP1 is exposed on the virion surface and at least three antigenic regions
are targeted by neutralizing antibodies [35]. As VP1 from the two serotypes of BRAV share ap-
proximately 85% amino acid identity, 140032–2 may represent a new serotype of BRBV how-
ever serological experiments are required to confirm this hypothesis.
Phylogenetic Analysis
To determine the evolutionary relationship between BRAV1, BRAV2 and BRBV, phylogenetic
analysis was performed on the P1 protein encoding capsid proteins VP1–4, as well as the highly
conserved 3D polymerase protein (Fig. 1). Analysis of P1 found that BRAV2 140032–1 and
BRBV 140032–2 formed well-defined clades with BRAV2 H-1 and BRBV EC-11, respectively,
while BRAV1 Sd-1 represented as an outlier most closely related to BRAV2. Phylogenetic anal-
ysis of 3D polymerase also found well-defined clades for BRBV and BRAV2 with BRAV1 as an
outlier closely related to BRAV2.
Table 3. Amino acid length and sequence identity (%) of BRBV strain 130024–2 and other bovine rhinitis viruses.
BRBV 140032–2 Protein Length (aa) % Identity BRAV1 Sd-1 % Identity BRAV2 H-1 % Identity BRAV2 140032–2 % Identity BRBV EC-11
L 207 39.4 38.9 40.9 92.8
VP4 92 66.0 67.0 66.0 96.7
VP2 228 43.2 42.8 43.2 93.0
VP3 219 52.3 50.9 50.5 93.6
VP1 219 36.0 36.9 37.7 86.8
2A 39 35.9 35.9 35.9 87.2
2B 127 40.6 39.9 39.9 94.5
2C 316 59.6 59.0 58.7 100.0
3A 133 27.1 27.1 26.3 92.5
3B 25 50.0 50.0 46.2 100.0
3C 208 57.6 57.6 57.1 98.1
3D 467 58.6 58.4 58.9 95.7
Total 2280 50.1 49.9 50.0 94.6
doi:10.1371/journal.pone.0121998.t003
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Molecular Epidemiology
As metagenomic sequencing of a nasal swab from a calf with acute respiratory disease identi-
fied concurrent infection with two bovine rhinitis virus species, we designed a 5’-nuclease re-
verse transcription PCR (rtPCR) assay targeting the conserved 3D polymerase gene to
investigate the incidence of BRV in BRDC diagnostic submissions. A subset of six samples pos-
itive on this assay were further confirmed as BRV by metagenomic sequencing (below). Assay
specificity was verified using pure cultures of common BRDC pathogens; all were negative.
Clinical samples from bovine respiratory disease submissions to KSVDL were previously
screened by a BRDC PCR panel which detects BVDV, BHV-1, BRSV and BCV [19]. Samples
were separately analyzed for IDV using a previously published method [20]. A total of 204
samples were screened. Thirteen of 204 samples (6.4%) were positive for BRV with Ct values
18.0–29.4. Positive samples originated from Kansas (n = 12) and Nebraska (n = 1). Nine sam-
ples were positive for BRV in addition to at least one other virus tested. Four samples were only
positive for BRV. Incidences for other viruses involved in BRDC pathogenesis were 36% for
BCV (n = 75), 4.8% for IDV (n = 10), 7% for BHV1 (n = 15), 5% for BVDV (n = 11) and 3%
for BRSV (n = 7). These results demonstrate that BRV are present in BRDC clinical samples
with a similar incidence to other established BRD etiological agents.
To further characterize a subset of the BRV positive samples, six samples were analyzed by
metagenomic sequencing in addition to the original sample 140032 from which BRAV2 and
BRBV genomes were assembled. Following subtraction of reads mapping to the host genome,
sequences were assembled de novo and the resulting contigs were analyzed by BLASTN against
Fig 1. Phylogenetic trees of the coding regions of a) P1 (VP4, VP2, VP3, VP1) and b) 3D polymerase.Maximum-likelihood analysis in combination with
1000 bootstrap replicates was used to derive trees based on the predicted protein sequences. A scale representing the number of amino acid changes is
shown in each panel.
doi:10.1371/journal.pone.0121998.g001
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a database of the BRV genomes (BRAV1 Sd-1, BRAV2 H-1, BRAV2 140032–1, BRBV EC-11,
BRBV 140032–2). An E value of1x10–5 is generally considered significant for organism iden-
tification by metagenomic sequencing [36]. One sample, 6–17, had four contigs with best blast
hits only to BRAV1 (Table 4, E values 8.9x10–78–6.1x10–146). Four samples, 5–52, 6–19, 20–76
and 21–22, showed evidence of co-infection with two different BRV (BRAV1 and BRAV2,
BRAV1 and BRBV, BRAV2 and BRBV). Sample 4–26 had multiple individual contigs with
high similarity to all three species/serotypes. Resequencing of 140032 found contigs mapping
to BRAV2 and BRBV similar to the initial analysis. Likewise, reanalysis of the raw data ob-
tained for the reference BRAV1 Sd-1 found contigs with BLASTN hits solely to BRAV1. Simi-
lar analysis of metagenomic sequences from a BRV PCR-negative nasal swab submitted for
BRD diagnostic testing failed to identify any contigs with E values>10–5 to BRV. Together,
these results suggest that co-infections with multiple species and/or serotypes of BRV are com-
mon in cattle. Similar observations were made during the discovery of BRBV, where analysis of
viral isolates from cattle with acute respiratory disease found 32 out of 38 isolated viruses were
BRAV1 using serum neutralization tests [8]. The remaining six isolates were not neutralized by
BRAV1 or BRBV antiserum and were subsequently shown to represent a new serotype,
BRAV2.
The six BRV-positive samples were also analyzed by BLASTN at the National Center for
Biotechnology Information using the nucleotide collection database. Reads mapping to the
host Bos Taurus were subtracted and the remaining reads were assembled de novo and the re-
sulting contigs were analyzed by BLASTN. Contigs with similarity to BRV were identified for
all six samples. No other bovine viruses were identified in four of the samples (4–26, 5–52,
6–19 and 20–76; Table 4). Bovine parainfluenza virus 3 (BPI3) was identified in sample 6–17
(E = 0.0). BLASTN analysis of 21–22 identified BCV (E = 0.0) and BRSV (E = 8.5x10–55). Anal-
ysis of 140032 identified bovine adenovirus 4 (BAdV4, E = 0.0) and BCV (E = 0.0). Viruses
Table 4. BLASTN results from de novo assembled metagenomic sequences of bovine rhinitis virus PCR-positive samples.
Sample Virus Contigs E value range Other viruses-NGSa Other viruses-RT-PCRb
4–26 BRAV1 3 3.1x10−64–5.7x10−120 None BRV (22.7), BCV (30.6)
BRAV2 2 5.4x10−120–0.0
BRBV 10 3.6x10−43–0.0
5–52 BRAV1 2 1.1x10−56–3.01x10−124 None BRV (22.6)
BRAV2 5 7.2x10−9–0.0
6–17 BRAV1 4 8.8x10−78–6.1x10−146 BPI3 (0.0) BRV (26.5)
6–19 BRAV1 2 5.5x10−68–7.4x10−73 None BRV (27.4), BCV (35.1)
BRBV 7 2.9x10−110–0.0
20–76 BRAV1 2 9.8x10−92–0.0 None BRV (22.5), BHV1 (34.0)
BRAV2 1 0.0
21–22 BRAV1 3 1.9x10−66–0.0 BCV (0.0), BRSV (8.5x10−55) BRV (18.8), BRSV (27.8), BCV (25.3), IDV (33.5)
BRAV2 7 1.3x10−74–0.0
140032 BRAV2 7 8.4x10−48–0.0 BAdV4 (0.0), BCV (0.0) BCV (20.0)
BRBV 16 7.8x10−52–0.0
BRAV Sd-1 BRAV1 2 0.0 None n.d.c
aViruses identiﬁed by BLASTN analysis of contigs assembled de novo. E values are in parentheses.
bViruses detected by the RT-PCR. Viruses screened by RT-PCR include BVDV, BCV, BRSV, BRV, BHV1 and IDV. Cycle threshold values are
in parentheses.
cnot determined
doi:10.1371/journal.pone.0121998.t004
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identified by metagenomic sequencing were in good agreement for those included in the
BRDC RT-PCR panel where Ct values were less than 30: for 21–22, both metagenomic se-
quencing and RT-PCR identified BCV and BRSV; for 140032, both assays detected BCV. The
inability for metagenomic sequencing to detect viruses with Ct values greater than 30 is likely
due to insufficient sensitivity.
Seroprevalence
Indirect immunofluorescence assays were performed on a collection of bovine sera using cell
culture adapted BRBV to determine seroprevalence. Sera represented 15 herds in six states. All
samples were positive with a titer of 160-640. Where age of animal was known (n = 44), the
minimum age was 9 months (n = 4) and the majority of animals were adults>2 years of age.
Controls including gnotobiotic calf antiserum, sera from high health animals held in isolation
and uninfected cells were negative. Attempts to perform IFA using BRAV1 and primary em-
bryonic bovine kidney cells were unsuccessful due to non-specific fluorescence. IFA was not
performed with BRAV2 as we were unable to acquire the virus. These results suggest that
BRBV infections are common in cattle however additional serological testing is needed to con-
firm these results. In particular, while BRAV and BRBV are serologically distinct from one an-
other in serum neutralization assays, cross reactivity between BRAV and BRBV in our IFA
assay was not performed [7]. Similar detection rates and seroprevalence were recently reported
for the newly described bovine IDV [37]. IDV was found in 4.8% of BRD diagnostic submis-
sions and serosurveys found 87.5% of herds and individuals had hemagglutination inhibition
assay titers greater than 40. Previous serological studies also found evidence for widespread
BRV infections [4,7,17,38,39].
While BRV are established etiological agents for BRDC, little work has been published on
these viruses over the past several decades. This is likely in part due to difficulty in isolating
these viruses in cell culture. Nearly all reports of BRV isolation utilized primary cells and the ti-
ters obtained in vitro were relatively low. Also, controlled animal inoculation with BRV re-
sulted in mild respiratory disease and histopathology. Combined, these results likely contribute
to the lack of research on these viruses. Advances in sequencing technology now allow re-
searchers to readily characterize metagenomic samples in a sequence-independent manner, en-
abling detection and characterization of both established and novel or neglected organisms.
The serological evidence for BRBV and molecular data for bovine rhinitis viruses herein
suggest that BRV infections are common components of BRDC. These results, combined with
previous controlled inoculation studies for BRAV1 and BRBV, suggest BRV are pathogens in-
volved in BRDC. While our results do not demonstrate a definitive role for BRV in BRDC
pathogenesis, we were unable to identify any other viruses present in over half of BRV-positive
BRDC clinical samples using metagenomic sequencing. Further research is needed to differen-
tiate the possibility of BRV being a non-pathogenic commensal organism. This first report of
BRAV2 and BRBV in U.S. cattle and the occurrence of concurrent mixed BRV co-infections
further expands our knowledge on the epidemiology of these viruses.
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